|
|
| 产品基本信息 |
|
| 产品编号：D209700 |
| 产品名称：3’-De-tert-butoxycarbonylamino-3’-[3-(5,5-dimethyl-2,4-dioxo-1,3-oxazo |
| 产品CAS：160651-94-5 |
| 规格含量：2mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
D209700 |
| 名称: |
3’-De-tert-butoxycarbonylamino-3’-[3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidinyl)] -7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel |
| 别名: |
[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]- α-Hydroxy-5,5-dimethyl- 2,4-dioxo-β-phenyl-3-Oxazolidinepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester; |
| CAS号: |
160651-94-5 |
| 分子式: |
C₄₉H₅₁Cl₆NO₁₉ |
| 分子量: |
1170.64 |
| 溶解性: |
Dichloromethane, Ethyl Acetate, Methanol |
| 种类: |
Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
An intermediate in partial synthesis of major human metabolites of Docetaxel (D494420), an antineoplastic. |
| 参考文献 |
|
|
|
|
您的位置：
